NNNN

Handel nachbörslich: 25.63 -0.515 -1.97%

Anbio Biotechnology (NNNN)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Anbio Biotechnology Stock (NNNN) Company Profile

Anbio Biotechnology

Healthcare (1116)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

NNNN's Discussions on Twitter

Compare NNNN vs ISRG, BDX, ALC, MDLN, RMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NNNN Anbio Biotechnology	26.14	1.13B	7.54M	2.82M	2.25M	0.0632
ISRG Intuitive Surgical Inc	452.58	160.56B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	155.32	43.95B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	74.63	36.34B	10.40B	980.00M	1.61B	1.9749
MDLN Medline Inc	43.88	35.94B	28.43B	1.16B	1.26B	1.4457
RMD Resmed Inc	224.93	32.65B	5.40B	1.49B	1.78B	10.12

Anbio Biotechnology Aktie (NNNN) Neueste Nachrichten

Finanzdaten der Anbio Biotechnology-Aktie (NNNN)

Anbio Biotechnology (NNNN)

Anbio Biotechnology Stock (NNNN) Company Profile

Compare NNNN vs ISRG, BDX, ALC, MDLN, RMD

Anbio Biotechnology Aktie (NNNN) Neueste Nachrichten

Exxon Mobil, Pepsico among market cap stock movers on Monday - Investing.com UK

Exxon Mobil, Pepsico among market cap stock movers on Monday By Investing.com - Investing.com Canada

Anbio Biotechnology (NNNN) Surges 11.6% Intraday – What’s Fueling the Volatility? - Bitget

Why Anbio Biotechnology Class A Shares Are Surging - tipranks.com

Why Anbio Biotechnology Class A Shares Are Jumping - TipRanks

Top Maplight Therapeutics (MPLT) Competitors 2026 - MarketBeat

Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum - The Manila Times

Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum on March 17, 2026 - geneonline.com

Anbio CEO to outline rapid diagnostic plans at KeyBanc investor event - Stock Titan

Aktis Oncology (AKTS) Stock Analysis Report | Financials & Insights - Benzinga Japan

Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) Head-To-Head Review - Defense World

Anbio Biotechnology and Oncocyte Compared in Financial Analysis - National Today

Anbio Biotechnology falls -5.8% - MSN

Head-To-Head Analysis: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Financial Analysis: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Anbio Biotechnology Stock Quote, Share Price, News and Analysis - Longbridge

Head to Head Contrast: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Anbio Biotechnology (NASDAQ:NNNN) vs. Oncocyte (NASDAQ:IMDX) Critical Comparison - Defense World

TechTarget (TTGT) to Release Earnings on Wednesday - Defense World

Anbio Biotechnology: Improved Margins, Still Priced For Growth That Isn't Showing Up - Seeking Alpha

NNNN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) Head to Head Contrast - Defense World

NNNN Technical Analysis & Stock Price Forecast - Intellectia AI

Anbio Biotechnology Outperforms Oncocyte in Financial Metrics - National Today

Anbio Biotechnology (NNNN) Stock Analysis: Navigating Volatility in the Medical Instruments Sector - DirectorsTalk Interviews

Critical Comparison: Oncocyte (NASDAQ:IMDX) vs. Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Anbio Biotechnology Outperforms Oncocyte in Head-to-Head Review - National Today

Celestica Inc. (TSE:CLS) Receives Average Recommendation of “Strong Buy” from Analysts - Defense World

Comparing Anbio Biotechnology (NASDAQ:NNNN) & Oncocyte (NASDAQ:IMDX) - Defense World

Financial Contrast: Oncocyte and Anbio Biotechnology - National Today

Head-To-Head Survey: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Reviewing Anbio Biotechnology (NASDAQ:NNNN) and Oncocyte (NASDAQ:IMDX) - Defense World

Diane Lazzaris Sells 2,747 Shares of WESCO International (NYSE:WCC) Stock - Defense World

Anbio Biotechnology and Oncocyte Compared: Which Stock Reigns Supreme? - National Today

Anbio Biotechnology (NNNN) Stock Analysis: What Investors Should Know About This German IVD Innovator - DirectorsTalk Interviews

Anbio Biotechnology prices $8M IPO at $5 per share - MSN

Oncocyte (NASDAQ:IMDX) vs. Anbio Biotechnology (NASDAQ:NNNN) Critical Comparison - Defense World

Anbio Biotechnology Replaces Auditor to Safeguard 2025 Reporting Timeline - TipRanks

Anbio Biotechnology (NNNN) names GGF CPA LTD as new independent auditor - Stock Titan

Head-To-Head Comparison: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World

IPO window reopens, med-tech class of 2025 gains 26% - bioworld.com

Head to Head Analysis: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World

COREwafer Industries Inc. (OTCMKTS:AHIX) Short Interest Up 126.9% in January - Defense World

GRAIL (GRAL) Projected to Post Earnings on Thursday - Defense World

Anbio Biotechnology (NASDAQ:NNNN) Stock Price Up 8.4%Should You Buy? - MarketBeat

Contrasting Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Financial Survey: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Financial Comparison: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Anbio Biotechnology and Oncocyte: A Financial Review - National Today

Critical Analysis: Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) - Defense World

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Finanzdaten der Anbio Biotechnology-Aktie (NNNN)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie NNNN